StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > OPINIONS

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 12, 2021 2:26pm

123 Views

Post# 32554548

RE:RE:OPINIONS

And I get there might be the odd investor that thinks if they complain in this forum that Tripp is going to put out news to pacify them but that's ridiculous as an excuse for isht posting, and no matter how much Tripp reads these posts he's not putting out news just to make a few rando retail investors happy. The people I'm arguing with have been here long enough to know that, and long enough to know what's really going on on this board, AND long enough to know better than to play into it, yet here we are in the best place this company has ever been, doubled our size in a year, with 55+ new partners, millions in revenue and Aristotle on our doorstep and they're still searching for things to complain about. It's not an accident, it's motivated and intentional.